1613236-40-0

Upstream product

• 1357095-12-5 3-bromo-4-(2,2,2-trifluoro-ethoxy)-pyridine 
• 1613239-12-5 N-(2-benzyloxy-1-cyano-1-methyl-ethyl)-2-methyl-propane-2-sulfinamide 
• 22539-93-1 3-benzyloxypropanone 
• 1613239-14-7 N-[2-benzyloxy-1-methyl-1-(5-methyl-1,2,4-oxadiazol-3-yl)ethyl]-2-methyl-propane-2-sulfinamide 
• 1613239-13-6 3-benzyloxy-2-(tert-butylsulfinylamino)-N'-hydroxy-2-methyl-propanamidine 
• 1613238-51-9 5-cyclopropyl-4-(2,2,2-trifluoro-ethoxy)-pyridine-2-carboxylic acid 
• 1613239-15-8 1-(benzyloxy)-2-(5-methyl-1,2,4-oxadiazol-3-yl)propan-2-amine 
• 1256790-74-5 4-chloro-5-cyclopropyl-pyridine-2-carboxylic acid 
• 1346544-23-7 4-chloro-3-cyclopropyl-pyridine 
• 36953-42-1 3-bromo-4-chloropyridine 

Relevant academic research and scientific papers

NOVEL PYRIDINE DERIVATIVES

The invention relates to a compound of formula (I); wherein A and R1 to R4 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.

PYRIDINE-2-AMIDES USEFUL AS CB2 AGONISTS

The invention relates to a compound of formula (I) wherein R1 to R4 are defined as in the description and in the claims. The compound of formula (I) is a CB2 agonist and can be used as an active ingredient in a medicament.